Surfactant proteins in pulmonary alveolar proteinosis in adults

European Respiratory Journal

Volumn 24, Issue 3, 2004, Pages 426-435

  Brasch, Frank E ^a,c   Birzele, J ^a   Ochs, M ^c   Guttentag, S H ^d   Schoch, O D ^f   Boehler, A ^g   Beers, M F ^d   Muller K M ^a   Hawgood, S ^e   Johnen, G ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Precursors of surfactant protein B; Pulmonary alveolar proteinosis; Surfactant

Indexed keywords

PROTEIN PRECURSOR; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; MALE; PALMITOYLATION; PATHOGENESIS; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RETROSPECTIVE STUDY; TRANSPORT VESICLE; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; RETROSPECTIVE STUDIES;

EID: 4544382326     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00076403     Document Type: Article

References (41)

1. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258: 1123-1142.
2. Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ. Autoantibodies against granulocyte-macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 2002; 27: 481-486.
3. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte-macrophage colony-stimulating factor. J Exp Med 1999; 190: 875-880.
4. Reed JA, Ikegami M, Cianciolo ER, et al. Aerosolized GPM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol 1999; 276: L556-L563.
5. Seymour JF, Presneill JJ, Schoch OD, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001; 163: 524-531.
6. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166: 215-235.
7. Wang BM, Stern EJ, Schmidt RA, Pierson DJ. Diagnosing pulmonary alveolar proteinosis. A review and an update. Chest 1997; 111: 460-466.
8. Martin RJ, Coalson JJ, Rogers RM, Horton FO, Manous LE. Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis 1980; 121: 819-825.
9. Gonzales LW, Angampalli S, Guttentag SH, et al. Maintenance of differentiated function of the surfactant system in human fetal lung type II epithelial cells cultured on plastic. Pediatr Pathol Mol Med 2001; 20: 387-412.
10. Solarin KO, Ballard PL, Guttentag SH, Lomax CA, Beers MF. Expression and glucocorticoid regulation of surfactant protein C in human fetal lung. Pediatr Res 1997; 42: 356-364.
11. Korimilli A, Gonzales LW, Guttentag SH. Intracellular localization of processing events in human surfactant protein B biosynthesis. J Biol Chem 2000; 275: 8672-8679.
12. Brasch F, Ten Brinke A, Johnen G, et al. Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes. Am J Respir Cell Mol Biol 2002; 26: 659-670.
13. Ochs M, Johnen G, Müller KM, et al. Intracellular and intraalveolar localization of surfactant protein A (SP-A) in the parenchymal region of the human lung. Am J Respir Cell Mol Biol 2002; 26: 91-98.
14. Brasch F, Johnen G, Winn-Brasch A, et al. Surfactant protein B in type II pneumocytes and intra-alveolar surfactant forms of human lungs. Am J Respir Cell Mol Biol 2004; 30: 449-458.
15. Reed JA, Ikegami M, Robb L, Begley CG, Ross G, Whitsett JA. Distinct changes in pulmonary surfactant homeostasis in common beta-chain- and GM-CSF-deficient mice. Am J Physiol Lung Cell Mol Physiol 2000; 278: L1164-L1171.
16. Hook GE. Alveolar proteinosis and phospholipidoses of the lungs. Toxicol Pathol 1991; 19: 482-513.
17. Huffman JA, Hull WM, Dranoff G, Mulligan RC, Whitsett JA. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J Clin Invest 1996; 97: 649-655.
18. Nishinakamura R, Wiler R, Dirksen U, et al. The pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation. J Exp Med 1996; 183: 2657-2662.
19. Robb L, Drinkwater CC, Metcalf D, et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci USA 1995; 92: 9565-9569.
20. Doyle IR, Davidson KG, Barr HA, Nicholas TE, Payne K, Pfitzner J. Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis. Am J Respir Crit Care Med 1998; 157: 658-664.
21. Crouch E, Persson A, Chang D. Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. Am J Pathol 1993; 142: 241-248.
22. Alberti A, Luisetti M, Braschi A, et al. Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. Am J Respir Crit Care Med 1996; 154: 817-820.
23. Honda Y, Takahashi H, Shijubo N, Kuroki Y, Akino T. Surfactant protein A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Chest 1993; 103: 496-499.
24. Voorhout WF, Veenendaal T, Haagsman HP, et al. Intracellular processing of pulmonary surfactant protein B in an endosomal/lysosomal compartment. Am J Physiol 1992; 263: L479-L486.
25. Phelps DS, Floros J. Localization of surfactant protein synthesis in human lung by in situ hybridization. Am Rev Respir Dis 1988; 137: 939-942.
26. Weaver TE. Synthesis, processing and secretion of surfactant proteins B and C. Biochim Biophys Acta 1998; 1408: 173-179.
27. Gobran LI, Rooney SA. Regulation of SP-B and SP-C secretion in rat type II cells in primary culture. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1413-L1419.
28. Vorbroker DK, Voorhout WF, Weaver TE, Whitsett JA. Post-translational processing of surfactant protein C in rat type II cells. Am J Physiol 1995; 269: L727-L733.
29. Johnson AL, Braidotti P, Pietra GG, et al. Post-translational processing of surfactant protein-C proprotein: targeting motifs in the NH(2)-terminal flanking domain are cleaved in late compartments. Am J Respir Cell Mol Biol 2001; 24: 253-263.
30. Conkright M, Bridges JP, Na CL, et al. Secretion of surfactant protein C, an integral membrane protein, requires the N-terminal propeptide. J Biol Chem 2001; 276: 14658-14664.
31. Lin S, Akinbi HT, Breslin JS, Weaver TE. Structural requirements for targeting of surfactant protein B (SP-B) to secretory granules in vitro and in vivo. J Biol Chem 1996; 271: 19689-19695.
32. Glasser SW, Burhans MS, Korfhagen TR, et al. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci USA 2001; 98: 6366-6371.
33. Clark JC, Wert SE, Bachurski CJ, et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995; 92: 7794-7798.
34. Johansson J. Structure and properties of surfactant protein C. Biochim Biophys Acta 1998; 1408: 161-172.
35. Stults JT, Griffin PR, Lesikar DD, Naidu A, Moffat B, Benson BJ. Lung surfactant protein SP-C from human, bovine, and canine sources contains palmityl cysteine thioester linkages. Am J Physiol 1991; 261: L118-L125.
36. Voss T, Schafer KP, Nielsen PF, et al. Primary structure differences of human surfactant-associated proteins isolated from normal and proteinosis lung. Biochim Biophys Acta 1992; 1138: 261-267.
37. Gustafsson M, Griffiths WJ, Furusjo E, Johansson J. The palmitoyl groups of lung surfactant protein C reduce unfolding into a fibrillogenic intermediate. J Mol Biol 2001; 310: 937-950.
38. Ten Brinke A, Batenburg JJ, Gadella BM, Haagsman HP, Vaandrager AB, van Golde LM. The juxtamembrane lysine and arginine residues of surfactant protein C precursor influence palmitoylation via effects on trafficking. Am J Respir Cell Mol Biol 2001; 25: 156-163.
39. Li ZY, Suzuki Y, Kurozumi M, Shen HQ, Duan CX. Removal of a dimeric form of surfactant protein C from mouse lungs: its acceleration by reduction. J Appl Physiol 1998; 84: 471-478.
40. Shen HQ, Duan CX, Li ZY, Suzuki Y. Effects of proteinosis surfactant proteins on the viability of rat alveolar macrophages. Am J Respir Crit Care Med 1997; 156: 1679-1687.
41. Osanai K, Mason RJ, Voelker DR. Trafficking of newly synthesized surfactant protein A in isolated rat alveolar type II cells. Am J Respir Cell Mol Biol 1998; 19: 929-935.